Evidence map›Paper›PMID 40689724›Full record

ArticleInvestigative ophthalmology & visual science2025

Deep Learning Model for Automated Classification of Macular Neovascularization Subtypes in AMD.

Giovanni Neri, Chiara Rebecchi, Jonathan D Oakley, Chiara Olivieri, Federico Ricardi, Paola Marolo, Daniel B Russakoff, Michele Reibaldi, Enrico Borrelli

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Clinical exit strategy in anti-VEGF therapy for neovascular AMD: incidence of recurrence and risk factors for relapse.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giovanni NeriDepartment of Surgical Sciences, University of Turin, Turin, Italy.
Chiara RebecchiDepartment of Surgical Sciences, University of Turin, Turin, Italy.
Jonathan D OakleyVoxeleron Inc., Austin, United States.
Chiara OlivieriDepartment of Surgical Sciences, University of Turin, Turin, Italy.
Federico RicardiDepartment of Surgical Sciences, University of Turin, Turin, Italy.
Paola MaroloDepartment of Surgical Sciences, University of Turin, Turin, Italy.
Daniel B RussakoffVoxeleron Inc., Austin, United States.
Michele ReibaldiDepartment of Surgical Sciences, University of Turin, Turin, Italy.
Enrico BorrelliDepartment of Surgical Sciences, University of Turin, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To develop a deep learning algorithm capable of accurately classifying macular neovascularization (MNV) subtypes in patients with treatment-naïve exudative neovascular age-related macular degeneration (AMD) using structural optical coherence tomography (OCT) images. Methods: In this retrospective cohort study, a total of 193 eyes with treatment-naïve neovascular AMD were included. Each case was classified into MNV subtypes (type 1, 2, or 3) based on structural OCT features. Convolutional neural network (CNN)-based deep learning models were trained using cross-validation to classify MNV subtypes. Preprocessing included homogenization of image data to optimize use of layer information for classification. Performance metrics included sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve (AUC), with and without homogenization. Results: Homogenized OCT data improved classification performance compared to non-homogenized data for all models. The highest reported sensitivity and specificity for type 1 MNV was 96.7% and 84.9%; for type 2, 100.0% and 85.5%; and, for type 3, 84.9% and 87.9%, respectively. The AUCs for type 1, 2, and 3 MNV were 0.95, 0.97, and 0.91, respectively. Occlusion sensitivity analysis revealed critical regions for classification, highlighting distinct anatomical differences among MNV subtypes. Conclusions: The proposed deep learning model demonstrated high accuracy in classifying MNV subtypes on structural OCT, with improved performance following homogenization. This tool could assist clinicians in accurately and efficiently diagnosing MNV subtypes, potentially influencing treatment decisions and patient outcomes in neovascular AMD.

Indexed as

Choroidal NeovascularizationDeep LearningMacula LuteaTomography, Optical CoherenceWet Macular DegenerationAgedAged, 80 and overAlgorithmsFemaleHumansMaleMiddle AgedRetrospective StudiesROC CurveSensitivity and Specificity

Identifiers

PMID40689724
PMCPMC12302047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.